Skip to main content Skip to left-side content

View Event Detail

Medicine Grand Rounds
4/17/2018 12:15 PM - 1:15 PM
Samis Education Center, Rainbolt Family Auditorium (map)

Pharmacologic treatment of Clostridium difficile infection

Chris Gentry, PharmD, BCPS, Chief, Pharmacy Service, Oklahoma City VA Healthcare System

Learning Objectives: 
Upon completion of this session, participants will improve their competence and performance by being able to:  Describe the epidemiology of Clostridium difficile infection.  Summarize the associated morbidity of Clostridium difficile, including the propensity for recurrence.  Contrast appropriate treatment strategies for Clostridium difficile infection in various settings and severities.

Professional Practice Gap:        
Gap 1.  New guidance on the treatment of non-severe Clostridium difficile infection and the current role of metronidazole in clinical practice.
Gap 2.  Evidence for alternative strategies for minimizing Clostridium difficile infection recurrence. 

Speaker Disclosures:       
Dr. Gentry has no relevant financial relationships or affiliations with commercial interests to disclose.  He will be discussing experimental or off-label drugs, therapies and/or devices that have not been approved by the FDA.

For further information contact:
Brenda Wilkerson
271-6651 ext. 54374